191 related articles for article (PubMed ID: 35801302)
1. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
Austhof E; Bell ML; Riddle MS; Catalfamo C; McFadden C; Cooper K; Scallan Walter E; Jacobs E; Pogreba-Brown K
Epidemiol Infect; 2022 Jul; 150():e136. PubMed ID: 35801302
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal symptoms related to the irritable bowel syndrome - a longitudinal population-based register study.
Heinsvig Poulsen C; Falgaard Eplov L; Hjorthøj C; Eliasen M; Frost Ebstrup J; Skovbjerg S; Schröder A; Jørgensen T
Scand J Gastroenterol; 2016; 51(4):420-6. PubMed ID: 26635123
[TBL] [Abstract][Full Text] [Related]
3. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study.
Ghoshal UC; Ghoshal U; Rahman MM; Mathur A; Rai S; Akhter M; Mostafa T; Islam MS; Haque SA; Pandey A; Kibria MG; Ahmed F
J Gastroenterol Hepatol; 2022 Mar; 37(3):489-498. PubMed ID: 34672022
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
5. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study.
Noviello D; Costantino A; Muscatello A; Bandera A; Consonni D; Vecchi M; Basilisco G
Neurogastroenterol Motil; 2022 Feb; 34(2):e14187. PubMed ID: 34060710
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.
Ashktorab H; Challa SR; Singh G; Nanduri S; Ibrahim M; Martirosyan Z; Whitsell P; Chirumamilla LG; Shayegh N; Watson K; Smith T; Ogwo V; Kolawole O; Littleton M; Morrison N; Nair V; Byer D; Dawodu DO; Lexima P; Rashid M; Deverapalli M; Atluri SM; Nezamloo A; Nasrin F; Kim RJ; Sherif Z; Oskrochi G; Carethers JM; Brim H
Dig Dis Sci; 2024 Feb; 69(2):562-569. PubMed ID: 38135813
[TBL] [Abstract][Full Text] [Related]
7. Post-infectious irritable bowel syndrome--a review of the literature.
Schwille-Kiuntke J; Frick JS; Zanger P; Enck P
Z Gastroenterol; 2011 Aug; 49(8):997-1003. PubMed ID: 21811952
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome.
Lo Vecchio A; Garazzino S; Smarrazzo A; Venturini E; Poeta M; Berlese P; Denina M; Meini A; Bosis S; Galli L; Cazzato S; Nicolini G; Vergine G; Giacchero R; Ballardini G; Dodi I; Salvini FM; Manzoni P; Ferrante G; Quadri V; Campana A; Badolato R; Villani A; Guarino A; Gattinara GC;
JAMA Netw Open; 2021 Dec; 4(12):e2139974. PubMed ID: 34928354
[TBL] [Abstract][Full Text] [Related]
9. Prolonged Gastrointestinal Manifestations After Recovery From COVID-19.
Elmunzer BJ; Palsson OS; Forbes N; Zakaria A; Davis C; Canakis A; Qayed E; Bick B; Pawa S; Tierney WM; McLeod CG; Taylor J; Patel H; Mendelsohn RB; Bala G; Sloan I; Merchant AA; Smith ZL; Sendzischew Shane MA; Aroniadis OC; Ordiah CO; Ruddy JM; Simren M; Tack J; Drossman D;
Clin Gastroenterol Hepatol; 2024 May; 22(5):1098-1107.e3. PubMed ID: 37995983
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms.
Settanni CR; Ianiro G; Ponziani FR; Bibbò S; Segal JP; Cammarota G; Gasbarrini A
World J Gastroenterol; 2021 Nov; 27(43):7433-7445. PubMed ID: 34887641
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic.
Gubatan J; Zikos T; Spear Bishop E; Wu J; Gottfried A; Becker L; Habtezion A; Neshatian L
Neurogastroenterol Motil; 2022 Apr; 34(4):e14243. PubMed ID: 34378840
[TBL] [Abstract][Full Text] [Related]
12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
13. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease.
Midenfjord I; Grinsvall C; Koj P; Carnerup I; Törnblom H; Simrén M
Neurogastroenterol Motil; 2021 Dec; 33(12):e14156. PubMed ID: 33860970
[TBL] [Abstract][Full Text] [Related]
14. Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea.
Schwille-Kiuntke J; Mazurak N; Enck P
Aliment Pharmacol Ther; 2015 Jun; 41(11):1029-37. PubMed ID: 25871571
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on incidence, risk factors, and validation of a risk score for post-infection irritable bowel syndrome in coastal eastern India.
Parida PK; Mishra D; Pati GK; Nath P; Dash KR; Behera SK; Parida S; Khatua CR; Panigrahi S; Mahapatra A; Khuntia HK; Singh SP
Indian J Gastroenterol; 2019 Apr; 38(2):134-142. PubMed ID: 30949908
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 infection causing residual gastrointestinal symptoms - a single UK centre case series.
Cooney J; Appiahene P; Findlay R; Al-Hillawi L; Rafique K; Laband W; Shandro B; Poullis A
Clin Med (Lond); 2022 Mar; 22(2):181-183. PubMed ID: 35105680
[TBL] [Abstract][Full Text] [Related]
17. Elucidating symptoms of COVID-19 illness in the Arizona CoVHORT: a longitudinal cohort study.
Khan SM; Farland LV; Catalfamo CJ; Austhof E; Bell ML; Chen Z; Cordova-Marks F; Ernst KC; Garcia-Filion P; Heslin KM; Hoskinson J; Jehn ML; Joseph ECS; Kelley CP; Klimentidis Y; Russo Carroll S; Kohler LN; Pogreba-Brown K; Jacobs ET
BMJ Open; 2022 Jan; 12(1):e053403. PubMed ID: 35039294
[TBL] [Abstract][Full Text] [Related]
18. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT.
Bell ML; Catalfamo CJ; Farland LV; Ernst KC; Jacobs ET; Klimentidis YC; Jehn M; Pogreba-Brown K
PLoS One; 2021; 16(8):e0254347. PubMed ID: 34347785
[TBL] [Abstract][Full Text] [Related]
19. Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?
Svendsen AT; Bytzer P; Engsbro AL
Scand J Gastroenterol; 2019 May; 54(5):546-562. PubMed ID: 31112663
[No Abstract] [Full Text] [Related]
20. The epidemiology of irritable bowel syndrome: Symptom development over a 3-year period in Denmark. A prospective, population-based cohort study.
Krogsgaard LR; Engsbro AL; Jones MP; Bytzer P
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27865035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
